• 1
    Eckert J. Epidemiology of Echinococcus multilocularis and E. granulosus in central Europe. Parasitologia 1997; 39: 337344.
  • 2
    Kilwinski J, Jenne L, Jellen-Ritter A, Radloff P, Flick W, Kern P. T lymphocyte cytokine profile at a single cell level in alveolar echinococcosis. Cytokine 1999; 11: 373381.
  • 3
    Yoshino I, Yano T, Murata M et al. Tumor-reactive T-cells accumulate in lung cancer tissues but fail to respond due to tumor cell-derived factor. Cancer Res 1992; 52: 775781.
  • 4
    Wick M, Dubey P, Koeppen H et al. Antigenic cancer cells grow progressively in immune hosts without evidence for T cell exhaustion or systemic anergy. J Exp Med 1997; 186: 229238.
  • 5
    Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271296.
  • 6
    Banchereau J & Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392: 245252.
  • 7
    Von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC. Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 1998; 188: 15471552.
  • 8
    Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996; 184: 747752.
  • 9
    Jonuleit H, Kuhn U, Muller G et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol 1997; 27: 31353142.
  • 10
    Wong C, Morse M, Nair SK. Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides. J Immunother 1998; 21: 3240.
  • 11
    Zitvogel L, Mayordomo JI, Tjandrawan T et al. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines. J Exp Med 1996; 183: 8797.
  • 12
    Mbow ML, Zeidner N, Panella N, Titus RG, Piesman J. Borrelia burgdorferi-pulsed dendritic cells induce a protective immune response against tick-transmitted spirochetes. Infect Immun 1997; 65: 33863390.
  • 13
    Sturm D, Menzel J, Gottstein B, Kern P. Interleukin-5 is the predominant cytokine produced by peripheral blood mononuclear cells in alveolar echinococcosis. Infect Immun 1995; 63: 16881697.
  • 14
    Espevik T & Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986; 95: 99105.
  • 15
    Jenne L, Arrighi JF, Jonuleit H, Saurat JH, Hauer C. Dendritic cells containing apoptotic melanoma cells prime human CD8+ T cells for efficient tumor cell lysis. Cancer Res 2000; 60: 44464452.
  • 16
    Dixon J & Jenkins P. Immunology of mammalian metacestode infections. II. Immune recognition and effector function. Helminthol Abstracts 1995; 1: 599613.
  • 17
    Kizaki T, Ishige M, Kobayashi S et al. Suppression of T-cell proliferation by CD8+ T cells induced in the presence of protoscolices of Echinococcus multilocularis in vitro. Infect Immun 1993; 61: 525533.
  • 18
    Inaba K, Inaba M, Naito M, Steinman RM. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette–Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J Exp Med 1993; 178: 479488.
  • 19
    Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995; 182: 389400.
  • 20
    Sallusto F & Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179: 11091118.
  • 21
    Maurer D, Fiebiger E, Reininger B et al. Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol 1998; 161: 27312739.
  • 22
    Stahl PD & Ezekowitz RA. The mannose receptor is a pattern recognition receptor involved in host defense. Curr Opin Immunol 1998; 10: 5055.
  • 23
    Kruisbeek AM & Amsen D. Mechanisms underlying T-cell tolerance. Curr Opin Immunol 1996; 8: 233244.
  • 24
    Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR. Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8 (+) T cells. J Exp Med 1997; 186: 239245.
  • 25
    Gottstein B & Hemphill A. Immunopathology of echinococcosis. Chem Immunol 1997; 66: 177208.
  • 26
    Sailer M, Soelder B, Allerberger F, Zaknun D, Feichtinger H, Gottstein B. Alveolar echinococcosis of the liver in a six-year-old girl with acquired immunodeficiency syndrome. J Pediatr 1997; 130: 320323.
  • 27
    Baron RW & Tanner CE. The effect of immunosuppression on secondary Echinococcus multilocularis infections in mice. Int J Parasitol 1976; 6: 3742.
  • 28
    Chaux P, Vantomme V, Coulie P, Boon T, Van Der Bruggen P. Estimation of the frequencies of anti-MAGE-3 cytolytic T-lymphocyte precursors in blood from individuals without cancer. Int J Cancer 1998; 77: 538542.
  • 29
    Ingold K, Gottstein B, Hemphill A. Identification of a laminated layer-associated protein in Echinococcus multilocularis metacestodes. Parasitology 1998; 116: 363372.
  • 30
    Rakha NK, Dixon JB, Carter SD, Craig PS, Jenkins P, Folkard S. Echinococcus multilocularis antigens modify accessory cell function of macrophages. Immunology 1991; 74: 652656.